Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2021-10-01 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings
2021-10-01 English
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letters dated 01st October, 2021, ....
Regulatory Filings
2021-10-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations. It informs about the trading window closure starting October 1, 2021, for the purpose of consideration and approval of unaudited financial results for the quarter and half year ended September 30, 2021. There is no actual financial data or report content included, only an announcement related to insider trading compliance and trading restrictions. The document length is short (1867 characters) and it serves as a notification rather than a financial report or detailed filing. Therefore, it does not qualify as an Interim/Quarterly Report (IR) or Earnings Release (ER). It is best classified as a Regulatory Filing (RNS) because it is a compliance-related announcement that does not fit other specific categories.
2021-09-30 English
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and in accordance with the Code of Conduct to Regulate, Monitor and Report of Trading by Insiders for trading ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading window closure starting October 1, 2021, for the purpose of consideration and approval of unaudited financial results for the quarter and half year ended September 30, 2021. The document does not contain any financial data or results itself, nor does it present a report or detailed financial information. It is an announcement related to insider trading compliance and trading restrictions around financial results disclosure. Given the short length (1867 characters) and the nature of the content, this is not a financial report or earnings release but a regulatory announcement. Therefore, the appropriate classification is Regulatory Filings (RNS), which covers compliance documents and miscellaneous regulatory announcements that do not fit other categories.
2021-09-30 English
Morepen carves out its Medical Devices into a Subsidiary.
Capital/Financing Update Classification · 95% confidence The document is a press release dated 29/09/2021 from Morepen Laboratories Limited announcing the carving out of its Medical Devices business into a wholly owned subsidiary, Morepen Devices Limited. It mentions shareholder approval at the 36th Annual General Meeting (AGM) but does not provide detailed financial statements or comprehensive financial performance data. The content focuses on business restructuring, strategic growth plans, and future capital raising intentions. There is no indication of this being a full annual report, interim report, earnings release, or any other detailed financial filing. It is a corporate announcement about a business segment carve-out and subsidiary formation, which aligns with a Capital/Financing Update. The document is over 11,000 characters, so it is not a brief announcement or report publication notice. Therefore, the best fitting category is Capital/Financing Update (CAP).
2021-09-29 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release dated 29/09/2021 from Morepen Laboratories Limited announcing the carving out of its Medical Devices business into a wholly owned subsidiary, Morepen Devices Limited. It mentions shareholder approval at the 36th Annual General Meeting (AGM) but does not provide detailed financial statements or comprehensive financial performance data. The content focuses on business restructuring, strategic growth plans, and future capital raising intentions. There is no indication of this being a full annual report, interim report, earnings release, or any other detailed financial filing. It is a corporate announcement about a business restructuring and subsidiary formation, which fits best under Capital/Financing Update (CAP) as it discusses the creation of a new entity and potential capital raising. The document length is substantial (over 11,000 characters) and contains substantive information, not just a brief announcement or certification. Therefore, the most appropriate classification is CAP with high confidence.
2021-09-29 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.